Compile Data Set for Download or QSAR
Report error Found 3831 Enz. Inhib. hit(s) with Target = 'Free fatty acid receptor 1'
TargetFree fatty acid receptor 1(Human)
Johnson & Johnson Pharmaceutical

LigandPNGBDBM22477(3-phenyl-3-(4-propoxyphenyl)propanoic acid | 3-Ary...)
Affinity DataEC50:  4.80E+3nMT: 2°CAssay Description: Human embryonic kidney (HEK293) cells expressing human GPR40 receptors were grown in Dulbecco modified Eagles medium (DMEM)/F12 media supplemented w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/30/2008
Entry Details Article
PubMed
TargetFree fatty acid receptor 1(Human)
Johnson & Johnson Pharmaceutical

LigandPNGBDBM22478(3-(4-butoxyphenyl)-3-phenylpropanoic acid | 3-Aryl...)
Affinity DataEC50:  1.20E+3nMT: 2°CAssay Description: Human embryonic kidney (HEK293) cells expressing human GPR40 receptors were grown in Dulbecco modified Eagles medium (DMEM)/F12 media supplemented w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/30/2008
Entry Details Article
PubMed
TargetFree fatty acid receptor 1(Human)
Johnson & Johnson Pharmaceutical

LigandPNGBDBM22479(3-[4-(pentyloxy)phenyl]-3-phenylpropanoic acid | 3...)
Affinity DataEC50:  2.97E+3nMT: 2°CAssay Description: Human embryonic kidney (HEK293) cells expressing human GPR40 receptors were grown in Dulbecco modified Eagles medium (DMEM)/F12 media supplemented w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/30/2008
Entry Details Article
PubMed
TargetFree fatty acid receptor 1(Human)
Johnson & Johnson Pharmaceutical

LigandPNGBDBM22480(3-[4-(hexyloxy)phenyl]-3-phenylpropanoic acid | 3-...)
Affinity DataEC50:  2.88E+3nMT: 2°CAssay Description: Human embryonic kidney (HEK293) cells expressing human GPR40 receptors were grown in Dulbecco modified Eagles medium (DMEM)/F12 media supplemented w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/30/2008
Entry Details Article
PubMed
TargetFree fatty acid receptor 1(Human)
Johnson & Johnson Pharmaceutical

LigandPNGBDBM22481(3-[4-(heptyloxy)phenyl]-3-phenylpropanoic acid | 3...)
Affinity DataEC50:  4.26E+3nMT: 2°CAssay Description: Human embryonic kidney (HEK293) cells expressing human GPR40 receptors were grown in Dulbecco modified Eagles medium (DMEM)/F12 media supplemented w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/30/2008
Entry Details Article
PubMed
TargetFree fatty acid receptor 1(Human)
Johnson & Johnson Pharmaceutical

LigandPNGBDBM22482(3-phenyl-3-[4-(4,4,4-trifluorobutoxy)phenyl]propan...)
Affinity DataEC50:  3.16E+3nMT: 2°CAssay Description: Human embryonic kidney (HEK293) cells expressing human GPR40 receptors were grown in Dulbecco modified Eagles medium (DMEM)/F12 media supplemented w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/30/2008
Entry Details Article
PubMed
TargetFree fatty acid receptor 1(Human)
Johnson & Johnson Pharmaceutical

LigandPNGBDBM22483(3-{4-[(2E)-but-2-en-1-yloxy]phenyl}-3-phenylpropan...)
Affinity DataEC50:  2.71E+3nMT: 2°CAssay Description: Human embryonic kidney (HEK293) cells expressing human GPR40 receptors were grown in Dulbecco modified Eagles medium (DMEM)/F12 media supplemented w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/30/2008
Entry Details Article
PubMed
TargetFree fatty acid receptor 1(Human)
Johnson & Johnson Pharmaceutical

LigandPNGBDBM22484(3-[4-(3-methoxypropoxy)phenyl]-3-phenylpropanoic a...)
Affinity DataEC50:  7.58E+3nMT: 2°CAssay Description: Human embryonic kidney (HEK293) cells expressing human GPR40 receptors were grown in Dulbecco modified Eagles medium (DMEM)/F12 media supplemented w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/30/2008
Entry Details Article
PubMed
TargetFree fatty acid receptor 1(Human)
Johnson & Johnson Pharmaceutical

LigandPNGBDBM22485(3-{4-[(3-methylbut-3-en-1-yl)oxy]phenyl}-3-phenylp...)
Affinity DataEC50:  2.71E+3nMT: 2°CAssay Description: Human embryonic kidney (HEK293) cells expressing human GPR40 receptors were grown in Dulbecco modified Eagles medium (DMEM)/F12 media supplemented w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/30/2008
Entry Details Article
PubMed
TargetFree fatty acid receptor 1(Human)
Johnson & Johnson Pharmaceutical

LigandPNGBDBM22486(3-[4-(3-methylbutoxy)phenyl]-3-phenylpropanoic aci...)
Affinity DataEC50:  1.86E+3nMT: 2°CAssay Description: Human embryonic kidney (HEK293) cells expressing human GPR40 receptors were grown in Dulbecco modified Eagles medium (DMEM)/F12 media supplemented w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/30/2008
Entry Details Article
PubMed
TargetFree fatty acid receptor 1(Human)
Johnson & Johnson Pharmaceutical

LigandPNGBDBM22487(3-[4-(2-methylbutoxy)phenyl]-3-phenylpropanoic aci...)
Affinity DataEC50:  300nMT: 2°CAssay Description: Human embryonic kidney (HEK293) cells expressing human GPR40 receptors were grown in Dulbecco modified Eagles medium (DMEM)/F12 media supplemented w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/30/2008
Entry Details Article
PubMed
TargetFree fatty acid receptor 1(Human)
Johnson & Johnson Pharmaceutical

LigandPNGBDBM22488(3-[4-(2-ethylbutoxy)phenyl]-3-phenylpropanoic acid...)
Affinity DataEC50:  640nMT: 2°CAssay Description: Human embryonic kidney (HEK293) cells expressing human GPR40 receptors were grown in Dulbecco modified Eagles medium (DMEM)/F12 media supplemented w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/30/2008
Entry Details Article
PubMed
TargetFree fatty acid receptor 1(Human)
Johnson & Johnson Pharmaceutical

LigandPNGBDBM22489(3-(4-butoxyphenyl)-3-(3-fluorophenyl)propanoic aci...)
Affinity DataEC50:  1.44E+3nMT: 2°CAssay Description: Human embryonic kidney (HEK293) cells expressing human GPR40 receptors were grown in Dulbecco modified Eagles medium (DMEM)/F12 media supplemented w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/30/2008
Entry Details Article
PubMed
TargetFree fatty acid receptor 1(Human)
Johnson & Johnson Pharmaceutical

LigandPNGBDBM22490(3-(4-butoxyphenyl)-3-[3-(trifluoromethyl)phenyl]pr...)
Affinity DataEC50:  2.84E+3nMT: 2°CAssay Description: Human embryonic kidney (HEK293) cells expressing human GPR40 receptors were grown in Dulbecco modified Eagles medium (DMEM)/F12 media supplemented w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/30/2008
Entry Details Article
PubMed
TargetFree fatty acid receptor 1(Human)
Johnson & Johnson Pharmaceutical

LigandPNGBDBM22491(3-(4-butoxyphenyl)-3-[4-(trifluoromethyl)phenyl]pr...)
Affinity DataEC50: >1.00E+4nMT: 2°CAssay Description: Human embryonic kidney (HEK293) cells expressing human GPR40 receptors were grown in Dulbecco modified Eagles medium (DMEM)/F12 media supplemented w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/30/2008
Entry Details Article
PubMed
TargetFree fatty acid receptor 1(Human)
Johnson & Johnson Pharmaceutical

LigandPNGBDBM22492(3-(4-butoxyphenyl)-3-(thiophen-2-yl)propanoic acid...)
Affinity DataEC50:  1.29E+3nMT: 2°CAssay Description: Human embryonic kidney (HEK293) cells expressing human GPR40 receptors were grown in Dulbecco modified Eagles medium (DMEM)/F12 media supplemented w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/30/2008
Entry Details Article
PubMed
TargetFree fatty acid receptor 1(Human)
Johnson & Johnson Pharmaceutical

LigandPNGBDBM22493(3-(4-butoxyphenyl)-3-(2-hydroxyphenyl)propanoic ac...)
Affinity DataEC50:  4.80E+3nMT: 2°CAssay Description: Human embryonic kidney (HEK293) cells expressing human GPR40 receptors were grown in Dulbecco modified Eagles medium (DMEM)/F12 media supplemented w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/30/2008
Entry Details Article
PubMed
TargetFree fatty acid receptor 1(Human)
Johnson & Johnson Pharmaceutical

LigandPNGBDBM22494(3-[3-(pentyloxy)phenyl]-3-phenylpropanoic acid | 3...)
Affinity DataEC50: >1.00E+4nMT: 2°CAssay Description: Human embryonic kidney (HEK293) cells expressing human GPR40 receptors were grown in Dulbecco modified Eagles medium (DMEM)/F12 media supplemented w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/30/2008
Entry Details Article
PubMed
TargetFree fatty acid receptor 1(Human)
Johnson & Johnson Pharmaceutical

LigandPNGBDBM22495(5-(4-butoxyphenyl)-5-phenylpentanoic acid | 5,5-di...)
Affinity DataEC50: >1.00E+4nMT: 2°CAssay Description: Human embryonic kidney (HEK293) cells expressing human GPR40 receptors were grown in Dulbecco modified Eagles medium (DMEM)/F12 media supplemented w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/30/2008
Entry Details Article
PubMed
TargetFree fatty acid receptor 1(Human)
Johnson & Johnson Pharmaceutical

LigandPNGBDBM22496(CHEMBL207881 | 3-(4-{[(3-phenoxyphenyl)methyl]amin...)
Affinity DataEC50:  79nMT: 2°CAssay Description:The reporter assay for the stable hGPR40-Gal4-Elk1/5xGal4-luc+-expressing CHO cells was first carried out in the serum-free medium in the presence of...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/30/2008
Entry Details Article
PubMed
TargetFree fatty acid receptor 1(Human)
Johnson & Johnson Pharmaceutical

LigandPNGBDBM22497(2-(4-{[(3-phenoxyphenyl)methyl]amino}phenyl)cyclop...)
Affinity DataEC50:  50nMT: 2°CAssay Description:The reporter assay for the stable hGPR40-Gal4-Elk1/5xGal4-luc+-expressing CHO cells was first carried out in the serum-free medium in the presence of...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/30/2008
Entry Details Article
PubMed
TargetFree fatty acid receptor 1(Human)
Johnson & Johnson Pharmaceutical

LigandPNGBDBM22498(3-(3-{[(3-phenoxyphenyl)methyl]amino}phenyl)propan...)
Affinity DataEC50:  398nMT: 2°CAssay Description:The reporter assay for the stable hGPR40-Gal4-Elk1/5xGal4-luc+-expressing CHO cells was first carried out in the serum-free medium in the presence of...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/30/2008
Entry Details Article
PubMed
TargetFree fatty acid receptor 1(Human)
Johnson & Johnson Pharmaceutical

LigandPNGBDBM22499(4-(4-{[(3-phenoxyphenyl)methyl]amino}phenyl)butano...)
Affinity DataEC50:  3.16E+3nMT: 2°CAssay Description:The reporter assay for the stable hGPR40-Gal4-Elk1/5xGal4-luc+-expressing CHO cells was first carried out in the serum-free medium in the presence of...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/30/2008
Entry Details Article
PubMed
TargetFree fatty acid receptor 1(Human)
Johnson & Johnson Pharmaceutical

LigandPNGBDBM22500(2-(4-{[(3-phenoxyphenyl)methyl]amino}phenyl)propan...)
Affinity DataEC50:  1.66E+4nMT: 2°CAssay Description:The reporter assay for the stable hGPR40-Gal4-Elk1/5xGal4-luc+-expressing CHO cells was first carried out in the serum-free medium in the presence of...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/30/2008
Entry Details Article
PubMed
TargetFree fatty acid receptor 1(Human)
Johnson & Johnson Pharmaceutical

LigandPNGBDBM22501(2-(4-{[(3-phenoxyphenyl)methyl]amino}phenyl)acetic...)
Affinity DataEC50:  3.98E+3nMT: 2°CAssay Description:The reporter assay for the stable hGPR40-Gal4-Elk1/5xGal4-luc+-expressing CHO cells was first carried out in the serum-free medium in the presence of...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/30/2008
Entry Details Article
PubMed
TargetFree fatty acid receptor 1(Human)
Johnson & Johnson Pharmaceutical

LigandPNGBDBM22502(3-(4-{[(4-phenylphenyl)methyl]amino}phenyl)propano...)
Affinity DataEC50:  251nMT: 2°CAssay Description:The reporter assay for the stable hGPR40-Gal4-Elk1/5xGal4-luc+-expressing CHO cells was first carried out in the serum-free medium in the presence of...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/30/2008
Entry Details Article
PubMed
TargetFree fatty acid receptor 1(Human)
Johnson & Johnson Pharmaceutical

LigandPNGBDBM22503(2-(4-{[(4-phenylphenyl)methyl]amino}phenyl)cyclopr...)
Affinity DataEC50:  40nMT: 2°CAssay Description:The reporter assay for the stable hGPR40-Gal4-Elk1/5xGal4-luc+-expressing CHO cells was first carried out in the serum-free medium in the presence of...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/30/2008
Entry Details Article
PubMed
TargetFree fatty acid receptor 1(Human)
Johnson & Johnson Pharmaceutical

LigandPNGBDBM22504(3-(3-{[(4-phenylphenyl)methyl]amino}phenyl)propano...)
Affinity DataEC50:  501nMT: 2°CAssay Description:The reporter assay for the stable hGPR40-Gal4-Elk1/5xGal4-luc+-expressing CHO cells was first carried out in the serum-free medium in the presence of...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/30/2008
Entry Details Article
PubMed
TargetFree fatty acid receptor 1(Human)
Johnson & Johnson Pharmaceutical

LigandPNGBDBM22505(4-(4-{[(4-phenylphenyl)methyl]amino}phenyl)butanoi...)
Affinity DataEC50:  1.59E+3nMT: 2°CAssay Description:The reporter assay for the stable hGPR40-Gal4-Elk1/5xGal4-luc+-expressing CHO cells was first carried out in the serum-free medium in the presence of...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/30/2008
Entry Details Article
PubMed
TargetFree fatty acid receptor 1(Human)
Johnson & Johnson Pharmaceutical

LigandPNGBDBM22506(2-(4-{[(4-phenylphenyl)methyl]amino}phenyl)propano...)
Affinity DataEC50: >3.16E+4nMT: 2°CAssay Description:The reporter assay for the stable hGPR40-Gal4-Elk1/5xGal4-luc+-expressing CHO cells was first carried out in the serum-free medium in the presence of...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/30/2008
Entry Details Article
PubMed
TargetFree fatty acid receptor 1(Human)
Johnson & Johnson Pharmaceutical

LigandPNGBDBM22507(2-(4-{[(4-phenylphenyl)methyl]amino}phenyl)acetic ...)
Affinity DataEC50:  1.23E+4nMT: 2°CAssay Description:The reporter assay for the stable hGPR40-Gal4-Elk1/5xGal4-luc+-expressing CHO cells was first carried out in the serum-free medium in the presence of...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/30/2008
Entry Details Article
PubMed
TargetFree fatty acid receptor 1(Human)
Johnson & Johnson Pharmaceutical

LigandPNGBDBM22508(3-(4-{[(3,4-dichlorophenyl)methyl]amino}phenyl)pro...)
Affinity DataEC50:  251nMT: 2°CAssay Description:The reporter assay for the stable hGPR40-Gal4-Elk1/5xGal4-luc+-expressing CHO cells was first carried out in the serum-free medium in the presence of...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/30/2008
Entry Details Article
PubMed
TargetFree fatty acid receptor 1(Human)
Johnson & Johnson Pharmaceutical

LigandPNGBDBM22509(3-{4-[(naphthalen-2-ylmethyl)amino]phenyl}propanoi...)
Affinity DataEC50:  794nMT: 2°CAssay Description:The reporter assay for the stable hGPR40-Gal4-Elk1/5xGal4-luc+-expressing CHO cells was first carried out in the serum-free medium in the presence of...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/30/2008
Entry Details Article
PubMed
TargetFree fatty acid receptor 1(Human)
Johnson & Johnson Pharmaceutical

LigandPNGBDBM22510(3-(4-{[(3-bromophenyl)methyl]amino}phenyl)propanoi...)
Affinity DataEC50:  794nMT: 2°CAssay Description:The reporter assay for the stable hGPR40-Gal4-Elk1/5xGal4-luc+-expressing CHO cells was first carried out in the serum-free medium in the presence of...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/30/2008
Entry Details Article
PubMed
TargetFree fatty acid receptor 1(Human)
Johnson & Johnson Pharmaceutical

LigandPNGBDBM22511(3-(4-{[(5-chlorothiophen-2-yl)methyl]amino}phenyl)...)
Affinity DataEC50:  2.00E+3nMT: 2°CAssay Description:The reporter assay for the stable hGPR40-Gal4-Elk1/5xGal4-luc+-expressing CHO cells was first carried out in the serum-free medium in the presence of...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/30/2008
Entry Details Article
PubMed
TargetFree fatty acid receptor 1(Human)
Johnson & Johnson Pharmaceutical

LigandPNGBDBM22512(3-[4-({[4-(trifluoromethyl)phenyl]methyl}amino)phe...)
Affinity DataEC50:  2.00E+3nMT: 2°CAssay Description:The reporter assay for the stable hGPR40-Gal4-Elk1/5xGal4-luc+-expressing CHO cells was first carried out in the serum-free medium in the presence of...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/30/2008
Entry Details Article
PubMed
TargetFree fatty acid receptor 1(Human)
Johnson & Johnson Pharmaceutical

LigandPNGBDBM22513(3-(4-{[(2-chlorophenyl)methyl]amino}phenyl)propano...)
Affinity DataEC50:  3.98E+3nMT: 2°CAssay Description:The reporter assay for the stable hGPR40-Gal4-Elk1/5xGal4-luc+-expressing CHO cells was first carried out in the serum-free medium in the presence of...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/30/2008
Entry Details Article
PubMed
TargetFree fatty acid receptor 1(Human)
Johnson & Johnson Pharmaceutical

LigandPNGBDBM22514(3-(4-{[(4-methylphenyl)methyl]amino}phenyl)propano...)
Affinity DataEC50:  3.98E+3nMT: 2°CAssay Description:The reporter assay for the stable hGPR40-Gal4-Elk1/5xGal4-luc+-expressing CHO cells was first carried out in the serum-free medium in the presence of...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/30/2008
Entry Details Article
PubMed
TargetFree fatty acid receptor 1(Human)
Johnson & Johnson Pharmaceutical

LigandPNGBDBM22515(3-(4-{[(3-fluorophenyl)methyl]amino}phenyl)propano...)
Affinity DataEC50:  5.01E+3nMT: 2°CAssay Description:The reporter assay for the stable hGPR40-Gal4-Elk1/5xGal4-luc+-expressing CHO cells was first carried out in the serum-free medium in the presence of...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/30/2008
Entry Details Article
PubMed
TargetFree fatty acid receptor 1(Human)
Johnson & Johnson Pharmaceutical

LigandPNGBDBM22516(3-[4-({[2-chloro-5-(trifluoromethyl)pyridin-3-yl]m...)
Affinity DataEC50:  5.01E+3nMT: 2°CAssay Description:The reporter assay for the stable hGPR40-Gal4-Elk1/5xGal4-luc+-expressing CHO cells was first carried out in the serum-free medium in the presence of...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/30/2008
Entry Details Article
PubMed
TargetFree fatty acid receptor 1(Human)
Johnson & Johnson Pharmaceutical

LigandPNGBDBM22517(3-[4-(benzylamino)phenyl]propanoic acid | carboxyl...)
Affinity DataEC50:  7.94E+3nMT: 2°CAssay Description:The reporter assay for the stable hGPR40-Gal4-Elk1/5xGal4-luc+-expressing CHO cells was first carried out in the serum-free medium in the presence of...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/30/2008
Entry Details Article
PubMed
TargetFree fatty acid receptor 1(Human)
Johnson & Johnson Pharmaceutical

LigandPNGBDBM22518(3-{4-[(pyridin-3-ylmethyl)amino]phenyl}propanoic a...)
Affinity DataEC50: >3.16E+4nMT: 2°CAssay Description:The reporter assay for the stable hGPR40-Gal4-Elk1/5xGal4-luc+-expressing CHO cells was first carried out in the serum-free medium in the presence of...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/30/2008
Entry Details Article
PubMed
TargetFree fatty acid receptor 1(Human)
Johnson & Johnson Pharmaceutical

LigandPNGBDBM22519(3-{4-[({4-[(dimethylamino)methyl]phenyl}methyl)ami...)
Affinity DataEC50: >3.16E+4nMT: 2°CAssay Description:The reporter assay for the stable hGPR40-Gal4-Elk1/5xGal4-luc+-expressing CHO cells was first carried out in the serum-free medium in the presence of...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/30/2008
Entry Details Article
PubMed
TargetFree fatty acid receptor 1(Human)
Johnson & Johnson Pharmaceutical

LigandPNGBDBM22520(3-{4-[(2H-1,3-benzodioxol-5-ylmethyl)amino]phenyl}...)
Affinity DataEC50: >3.16E+4nMT: 2°CAssay Description:The reporter assay for the stable hGPR40-Gal4-Elk1/5xGal4-luc+-expressing CHO cells was first carried out in the serum-free medium in the presence of...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/30/2008
Entry Details Article
PubMed
TargetFree fatty acid receptor 1(Human)
Johnson & Johnson Pharmaceutical

LigandPNGBDBM22521(4-({[4-(2-carboxyethyl)phenyl]amino}methyl)benzoic...)
Affinity DataEC50: >3.16E+4nMT: 2°CAssay Description:The reporter assay for the stable hGPR40-Gal4-Elk1/5xGal4-luc+-expressing CHO cells was first carried out in the serum-free medium in the presence of...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/30/2008
Entry Details Article
PubMed
TargetFree fatty acid receptor 1(Human)
Johnson & Johnson Pharmaceutical

LigandPNGBDBM22522(3-(4-{[(4-hydroxyphenyl)methyl]amino}phenyl)propan...)
Affinity DataEC50: >3.16E+4nMT: 2°CAssay Description:The reporter assay for the stable hGPR40-Gal4-Elk1/5xGal4-luc+-expressing CHO cells was first carried out in the serum-free medium in the presence of...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/30/2008
Entry Details Article
PubMed
TargetFree fatty acid receptor 1(Human)
Johnson & Johnson Pharmaceutical

LigandPNGBDBM22523(3-(4-{[(4-cyanophenyl)methyl]amino}phenyl)propanoi...)
Affinity DataEC50: >3.16E+4nMT: 2°CAssay Description:The reporter assay for the stable hGPR40-Gal4-Elk1/5xGal4-luc+-expressing CHO cells was first carried out in the serum-free medium in the presence of...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/30/2008
Entry Details Article
PubMed
TargetFree fatty acid receptor 1(Human)
Johnson & Johnson Pharmaceutical

LigandPNGBDBM22524(3-(4-{[(4-methoxyphenyl)methyl]amino}phenyl)propan...)
Affinity DataEC50:  1.26E+3nMT: 2°CAssay Description:The reporter assay for the stable hGPR40-Gal4-Elk1/5xGal4-luc+-expressing CHO cells was first carried out in the serum-free medium in the presence of...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/30/2008
Entry Details Article
PubMed
TargetFree fatty acid receptor 1(Human)
Johnson & Johnson Pharmaceutical

LigandPNGBDBM22525(3-(4-{[(3-carbamoylphenyl)methyl]amino}phenyl)prop...)
Affinity DataEC50: >3.16E+4nMT: 2°CAssay Description:The reporter assay for the stable hGPR40-Gal4-Elk1/5xGal4-luc+-expressing CHO cells was first carried out in the serum-free medium in the presence of...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/30/2008
Entry Details Article
PubMed
TargetFree fatty acid receptor 1(Human)
Johnson & Johnson Pharmaceutical

LigandPNGBDBM22526(3-{4-[(1H-imidazol-2-ylmethyl)amino]phenyl}propano...)
Affinity DataEC50: >3.16E+4nMT: 2°CAssay Description:The reporter assay for the stable hGPR40-Gal4-Elk1/5xGal4-luc+-expressing CHO cells was first carried out in the serum-free medium in the presence of...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/30/2008
Entry Details Article
PubMed
Displayed 1 to 50 (of 3831 total ) | Next | Last >>
Jump to: